Main Menu
TheraLect is a BioTech company which leverages the antimicrobial properties and healing activities of Lectins (protein) founds in plants to manage symptoms and treat human disease.
The innovation of the company’s technology platform, rooted in cutting-edge DNA technology, is a novel recombinant plant lectin with positive Phase IIa, resulting in epithelial healing.
TheraLect is a BioTech company which leverages the antimicrobial properties and healing activities of Lectins (protein) founds in plants to manage symptoms and treat human disease.
The innovation of the company’s technology platform, rooted in cutting-edge DNA technology, is a novel recombinant plant lectin with positive Phase IIa, resulting in epithelial healing.
Addressing unmet medical needs in high-prevalence disorders
Increasing patient reach to treatment via synthetic recreation of a natural protein
© 2023 ESGTI AG. All rights reserved · Legal Notice · Privacy Policy